MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI): stock profile, AI score and financials

MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MRVI at 24.7/100 on a composite quality score built from its SEC filings, placing it at rank #2,651 of 2,925 stocks — the bottom half of the AI-ranked universe. MRVI scores in the top quartile across institutional flow (94.8). Areas of concern include revenue growth (6.7) and profitability (13.4), which score below median versus the broader universe. Shareholder dilution risk is elevated at 10.7/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), MARAVAI LIFESCIENCES HOLDINGS, INC. reports quarterly revenue of $51.4M, net income of $-12.4M, an operating margin of -29.3%. Top institutional holders of MRVI by reported 13-F value include GTCR, BlackRock, BRAIDWELL, based on the most recent SEC filings. MRVI trades on the Nasdaq exchange and files with the SEC under CIK 1823239. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MRVI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MARAVAI LIFESCIENCES HOLDINGS, INC. directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 1823239 →